Medications

FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.

Diseases, Conditions, Syndromes

US faces wave of omicron deaths in coming weeks, models say

The fast-moving omicron variant may cause less severe disease on average, but COVID-19 deaths in the U.S. are climbing and modelers forecast 50,000 to 300,000 more Americans could die by the time the wave subsides in mid-March.

Diseases, Conditions, Syndromes

Daily virus cases in Russia double as omicron spreads

Russian authorities on Monday reported a sharp spike in new coronavirus cases, apparently driven by the rapid spread of the omicron variant health officials warned about last week.

Diseases, Conditions, Syndromes

Russia sees sharp rise in virus cases amid new surge fears

Russia on Thursday recorded a sharp increase in coronavirus cases amid warnings by government officials that another surge in infections driven by the highly contagious omicron variant could be on its way.

page 1 from 14